Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:vaccine
|
| gptkbp:administered_by |
gptkb:children
gptkb:National_Immunization_Days oral route infants young children toddlers drops multiple doses |
| gptkbp:contains |
live attenuated poliovirus
|
| gptkbp:developed_by |
gptkb:Albert_Bruce_Sabin
|
| gptkbp:has_achieved |
polio eradication goals
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sabin vaccine
|
| gptkbp:introduced_in |
gptkb:1961
|
| gptkbp:is_associated_with |
gptkb:virus
|
| gptkbp:is_available_in |
liquid form
single-dose vials |
| gptkbp:is_considered |
safe and effective
a public health success a cornerstone of public health a key tool in polio eradication |
| gptkbp:is_distributed_by |
health organizations
|
| gptkbp:is_effective_against |
gptkb:inactivated_polio_vaccine
all three types of poliovirus |
| gptkbp:is_evaluated_by |
clinical trials
safety and efficacy |
| gptkbp:is_linked_to |
herd immunity
community immunity immunity development |
| gptkbp:is_part_of |
gptkb:global_polio_eradication_initiative
public health initiatives vaccination campaigns global health efforts WHO vaccination programs immunization strategies routine immunization schedule in many countries |
| gptkbp:is_promoted_by |
non-governmental organizations
|
| gptkbp:is_protected_by |
gptkb:poliomyelitis
|
| gptkbp:is_recommended_by |
gptkb:CDC
gptkb:WHO mass immunization campaigns |
| gptkbp:is_storable_at |
room temperature
|
| gptkbp:is_subject_to |
regulatory approval
|
| gptkbp:is_used_in |
developing countries
|
| gptkbp:monitors |
polio outbreaks
|
| gptkbp:replaced_by |
inactivated polio vaccine in some countries
|
| gptkbp:side_effect |
allergic reactions
diarrhea mild fever |
| gptkbp:suitable_for |
immunocompromised individuals
|
| gptkbp:type |
oral polio vaccine
|
| gptkbp:bfsParent |
gptkb:Albert_Bruce_Sabin
|
| gptkbp:bfsLayer |
5
|